Search hospitals

>

California

>

Whittier

Medvin Clinical Research

Claim this profile

Whittier, California 90606

Global Leader in Rheumatoid Arthritis

Conducts research for Psoriatic Arthritis

Conducts research for Traumatic Arthropathy

Conducts research for Musculoskeletal Disorder

Conducts research for Osteoarthritis

22 reported clinical trials

2 medical researchers

Photo of Medvin Clinical Research in WhittierPhoto of Medvin Clinical Research in WhittierPhoto of Medvin Clinical Research in Whittier

Summary

Medvin Clinical Research is a medical facility located in Whittier, California. This center is recognized for care of Rheumatoid Arthritis, Psoriatic Arthritis, Traumatic Arthropathy, Musculoskeletal Disorder, Osteoarthritis and other specialties. Medvin Clinical Research is involved with conducting 22 clinical trials across 19 conditions. There are 2 research doctors associated with this hospital, such as Warren Boling, MD and Tien-I Karleen Su, MD.

Area of expertise

1

Rheumatoid Arthritis

Global Leader

Medvin Clinical Research has run 17 trials for Rheumatoid Arthritis. Some of their research focus areas include:

RF positive
Anti-CCP positive
ACPA positive
2

Psoriatic Arthritis

Medvin Clinical Research has run 4 trials for Psoriatic Arthritis.

Top PIs

Warren Boling, MD

Medvin Clinical Research

4 years of reported clinical research

Studies Arthritis
Studies Rheumatoid Arthritis
2 reported clinical trials
2 drugs studied

Tien-I Karleen Su, MD

Medvin Clinical Research

4 years of reported clinical research

Studies Rheumatoid Arthritis
Studies Arthritis
2 reported clinical trials
3 drugs studied

Clinical Trials running at Medvin Clinical Research

Psoriatic Arthritis

Rheumatoid Arthritis

Image of trial facility.

Zasocitinib

for Psoriatic Arthritis

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA who have not previously been treated with biologic disease-modifying antirheumatic drugs. The participants will be treated with either zasocitinib, active comparator, or placebo. Participants will be in the study for up to 60 weeks.

Recruiting

1 award

Phase 3

5 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at Medvin Clinical Research?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.